Track topics on Twitter Track topics that are important to you
San Francisco, CA, June 4, 2015 (GLOBE NEWSWIRE) -- Customer experience solutions company Touchpoint Metrics Inc. (OTCQB:TPOI) today announced that Mr. Stephen Shay has joined the company as Vice President.
A key member of the company's management team, Mr. Shay will
serve a strategic leadership role across multiple aspects of the
business. In addition to helping define and execute on company
strategy, his key responsibilities will include building and
scaling sales and distribution capabilities to help generate
demand, and drive revenue across all product and service lines. In
addition, he will play a key role in defining non-organic growth
and integration strategies.
"Stephen has an impressive track record of successfully building and leading customer- and partner-focused sales teams," said Michael Hinshaw, CEO of Touchpoint Metrics. "As importantly, his expertise as a customer experience executive in a global technology leader, and his experience identifying and successfully integrating close to a hundred technology company acquisitions is a significant asset. We are thrilled to have Stephen join our leadership team, and look forward to working closely with him to accelerate Touchpoint Metrics growth in the fast-moving months and years ahead."
Prior to joining Touchpoint Metrics, Mr. Shay enjoyed a nearly 21 year career with Microsoft Corporation, where he served as an executive leader in key roles across sales, operations and IT. Most recently, he served as General Manager, Customer Experience from 2010 through 2014, where he was responsible for strategy development and transformational change management of Microsoft's global organizational approach to delivering Connected Customer Experiences. In this role, he drove high-impact initiatives that helped to transform the customer centricity of the organization, delivering simplified, seamless omni-channel interactions across employee, customer and partner lifecycles.
As General Manager, Strategy & Business Development from
2005 to 2010, he led the sales, marketing and services functions
supporting the company's acquisition growth strategy - building
monetization and integration strategies for 90+ acquisitions with a
total consideration of $13 Billion. Prior to this, Mr. Shay held
executive leadership positions across Infrastructure Optimization
where he was responsible for accelerating the global adoption and
deployment of Microsoft technology by Enterprise customers, and in
Enterprise Technical Sales where he defined strategies, built tools
and programs in support of and provided leadership for the 2,200
member global technical sales team.
"Having led sales, marketing and technical organizations for over 20 years, my passion for the discipline of customer experience management is a logical one. From the perspective of an Enterprise Technology leader, I saw time and again the importance of aligning customer, partner and employee expectations with what organizations actually delivered to them. This perspective was a leading factor in the high success rates I enjoyed integrating over 90 acquisitions," said Mr. Shay. "I'm thrilled to join an innovation-driven leader like Touchpoint Metrics, and really look forward to working closely with our customers, partners and the entire team to help chart and drive growth in one of the most relevant, exciting and fast-moving industries there is today," he concluded.
Mr. Shay earned a Bachelor of Science Degree in Management &
Computer Information Systems from Park University, Kansas City,
Missouri and completed additional undergraduate studies in
architecture at the University of Kansas.
About Touchpoint Metrics
Touchpoint Metrics is a customer experience software, solutions and services company. Touchpoint Mapping®--our signature product and approach to quantifying customer experience--has driven significant business results for some of the world's leading companies, automatically mapping the complex, cross-channel maze of touchpoints that drive customer experience. A pioneer in the fast-growing customer experience services and technology sector, our proprietary approach and cloud-based software deliver actionable data and on-demand "Voice-of-the Customer" insights to dramatically improve customer experience, brand position, customer and employee satisfaction, loyalty and engagement for leaders in financial services, retail, technology, consumer products, and other industries.
General Information: 1-855-938-8100 toll free in the U.S., or
Media: Denise Marshall at 1-415-938-8100, Ext. 706
Investors: Andrew Barwicki 1-516-662-9461
This press release includes a number of forward-looking statements that may reflect our current views with respect to future events and financial performance. Forward-looking statements are often identified by words like: "believe," "expect," "plan," "estimate," "anticipate," "intend," "project," "will," "predicts," "seeks," "may," "would," "could," "potential," "continue," "ongoing," "should" and similar expressions, or words which, by their nature, refer to future events. You should not place undue certainty on these forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or from our predictions. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events, or otherwise.
CONTACT: General Information: 1-855-938-8100 toll free in the U.S., or +1-415-938-8100 Media: Denise Marshall at 1-415-938-8100, Ext. 706 Investors: Andrew Barwicki 1-516-662-9461NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...